Are abatacept and tocilizumab intravenous users willing to switch for the subcutaneous route of administration? A questionnaire-based study.

about

Patients', physicians', nurses', and pharmacists' preferences on the characteristics of biologic agents used in the treatment of rheumatic diseases The use of intravenous versus subcutaneous monoclonal antibodies in the treatment of severe asthma: a review

P2860

Q58558578-76B62C2A-0093-40A3-81C0-DFA439629946 Q58773859-32C6CDFD-191C-42D7-8978-9722229CABB2

P2860

Are abatacept and tocilizumab intravenous users willing to switch for the subcutaneous route of administration? A questionnaire-based study.

Item

http://www.wikidata.org/entity/Q47970691

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Are abatacept and tocilizumab ...... ? A questionnaire-based study.

@en

Are abatacept and tocilizumab ...... ? A questionnaire-based study.

@nl

type

Item

label

Are abatacept and tocilizumab ...... ? A questionnaire-based study.

@en

Are abatacept and tocilizumab ...... ? A questionnaire-based study.

@nl

prefLabel

Are abatacept and tocilizumab ...... ? A questionnaire-based study.

@en

Are abatacept and tocilizumab ...... ? A questionnaire-based study.

@nl

P1476

Are abatacept and tocilizumab ...... ? A questionnaire-based study.

@en

P2093

Eric Houvenagel

http://www.w3.org/2001/XMLSchema#string

Germain Jelin

http://www.w3.org/2001/XMLSchema#string

Laurène Norberciak

http://www.w3.org/2001/XMLSchema#string

Marie Desplats

http://www.w3.org/2001/XMLSchema#string

Peggy Philippe

http://www.w3.org/2001/XMLSchema#string

René-Marc Flipo

http://www.w3.org/2001/XMLSchema#string

P2860

The importance of patient preferences in treatment decisions--challenges for doctors.

Long-term safety of subcutaneous abatacept in rheumatoid arthritis: integrated analysis of clinical trial data representing more than four years of treatment.

Impact of inadequate adherence on response to subcutaneously administered anti-tumour necrosis factor drugs: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort

The influence of behavioural and psychological factors on medication adherence over time in rheumatoid arthritis patients: a study in the biologics era.

Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis.

Implications of subcutaneous or intravenous delivery of trastuzumab; further insight from patient interviews in the PrefHer study.

Economic considerations and patients' preferences affect treatment selection for patients with rheumatoid arthritis: a discrete choice experiment among European rheumatologists.

Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA)

Estimating effectiveness and cost of biologics for rheumatoid arthritis: application of a validated algorithm to commercial insurance claims.

Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study.

P304

1395-1400

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10067-017-3587-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Vincent Goeb

Tristan Pascart

P577

2017-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28255739

http://www.w3.org/2001/XMLSchema#string

P921

questionnaire

Are abatacept and tocilizumab intravenous users willing to switch for the subcutaneous route of administration? A questionnaire-based study.

about

P2860

P2860

Are abatacept and tocilizumab intravenous users willing to switch for the subcutaneous route of administration? A questionnaire-based study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921